Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcus aureus is a gram-positive bacterium commonly found on the skin and in the nose of humans. It is an opportunistic pathogen capable of causing a wide range of infections, from minor skin conditions to life-threatening systemic diseases. Its high propensity for developing antibiotic resistance, particularly methicillin resistance (MRSA), poses a significant clinical challenge. S. aureus produces numerous virulence factors and employs sophisticated immune evasion strategies, contributing to its pathogenicity and persistence. No vaccine is currently available.
N/A - target is an organism, not a specific molecule. Antibiotics target various bacterial processes (cell wall synthesis, protein synthesis, etc.)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus (S. aureus).